Stealth BioTherapeutics Corp - ADR
MITO
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-20,052,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.16 |
| Beta | 1.46 |
| Outstanding Shares | 59,620,373 |
Return
| Return on Equity | 103.77% |
|---|---|
| Return on Assets | -147.06% |
| Return on Invested Capital | -178.71% |
Valuation & Multiples
| P/E Ratio | -0.28 |
|---|---|
| PEG | 0.42 |
| Price to Sales | - |
| Price to Book Ratio | -0.32 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.42 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.69 |
| Debt to Equity | -0.26 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Stealth BioTherapeutics Corp
2,020 employeesStealth BioTherapeutics Corp is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every ...